Suppr超能文献

钙化防御的早期临床表现和进展。

Early clinical presentations and progression of calciphylaxis.

机构信息

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Department of Dermatology, Mayo Clinic, Rochester, MN, USA.

出版信息

Int J Dermatol. 2017 Aug;56(8):856-861. doi: 10.1111/ijd.13622. Epub 2017 Apr 23.

Abstract

BACKGROUND

Untreated calciphylaxis is a fatal disease of intra- and extravascular calcification, most commonly presenting in end-stage renal disease (ESRD) patients. While early identification is critical for timely treatment, early-stage clinical and histopathological descriptions have not, to our knowledge, been elucidated. As early clinical recognition is essential to prompt definitive histopathological diagnosis, this study describes a range of clinical and histopathological manifestations of early-stage calciphylaxis.

METHODS

Five patients with clinical photographs of lesions of early-phase calciphylaxis were chosen from a recent database of 101 patients. Their clinical histories were reviewed and correlated with their respective clinical and histopathological images of early-stage disease and progression of the disease.

RESULTS

Two of the five patients were identified early to have calciphylaxis and were promptly initiated on aggressive, multimodal therapy, resulting in complete resolution and remission of calciphylaxis. The other three patients were also recognized in early stages, one without renal disease, although the disease had progressed to more advanced stages associated with greater morbidity and mortality.

CONCLUSIONS

These cases demonstrate that calciphylaxis may be clinically misdiagnosed due to ill-defined presentations, particularly in the early stages without the characteristic features of livedo racemosa and ulceration. However, recognition in the early stages is critical to implement timely treatment. As such, definitively diagnostic skin biopsy should be considered early in suspected cases to confirm the diagnosis of calciphylaxis and ensure prompt management of this lethal disease.

摘要

背景

未经治疗的钙化防御是一种血管内和血管外钙化的致命疾病,最常发生在终末期肾病(ESRD)患者中。虽然早期识别对于及时治疗至关重要,但据我们所知,尚未阐明早期的临床和组织病理学描述。由于早期临床识别对于及时进行明确的组织病理学诊断至关重要,因此本研究描述了钙化防御早期的一系列临床和组织病理学表现。

方法

从最近的 101 例患者数据库中选择了 5 例具有钙化防御早期病变临床照片的患者。回顾了他们的病史,并将其与各自的早期疾病和疾病进展的临床和组织病理学图像相关联。

结果

其中 2 例患者被早期识别为钙化防御,并立即开始进行积极的多模式治疗,导致钙化防御完全缓解和消退。其他 3 例患者也在早期被识别出来,其中 1 例没有肾脏疾病,但疾病已经进展到与更高发病率和死亡率相关的更晚期阶段。

结论

这些病例表明,由于临床表现不明确,特别是在没有网状青斑和溃疡等特征性表现的早期阶段,钙化防御可能会被临床误诊。然而,早期识别对于及时治疗至关重要。因此,在疑似病例中应尽早进行明确诊断的皮肤活检,以确认钙化防御的诊断,并确保及时管理这种致命疾病。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验